Non Hodgkin Lymphoma Clinical Trial

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

Summary

To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplant for a disease in which a research question is not being addressed and for which peer reviewed, published data have demonstrated efficacy for this treatment approach.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant

Exclusion Criteria:

participation in any other treatment research protocol

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

2000

Study ID:

NCT01890486

Recruitment Status:

Recruiting

Sponsor:

Wake Forest University Health Sciences

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Wake Forest Baptist Health
Winston-Salem North Carolina, 27157, United States More Info
David Hurd, MD
Contact
336-716-2843
[email protected]
David Hurd, MD
Principal Investigator

How clear is this clinincal trial information?

Study is for people with:

Non Hodgkin Lymphoma

Estimated Enrollment:

2000

Study ID:

NCT01890486

Recruitment Status:

Recruiting

Sponsor:


Wake Forest University Health Sciences

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.